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similar transcriptomic profile with, in particular, reduced 
expression of murine Tert. Our results link classical micro-
glia activation with repression of telomere-associated 
genes, suggesting a new mechanism underlying microglia 
dysfunction.
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Introduction
Telomere dysfunction has been implicated in cellular 
senescence and pathological aging. Apart from its canoni-
cal role in telomere extension in dividing cells, TERT, 
the catalytic subunit of telomerase, has also been shown 
to interact with mitochondrial proteins [1]. Mice null for 
telomerase reverse transcriptase display repression of per-
oxisome proliferator-activated receptor ɣ coactivator 1 α 
and β (PGC-1α and PGC-1β), metabolic compromise and 
reduced mitochondrial biogenesis and function (“PGC net-
work”; [2]).
Microglia/brain macrophages play a crucial role in 
neurodegenerative and neuropsychiatric disease. Tradi-
tionally, two main patterns of microglia activation are 
distinguished: the so-called M1 (classical, LPS-induced) 
and M2 phenotypes (“alternatively activated,” stimu-
lated by IL-4). Here, we studied the PGC gene network 
in M1 and M2 microglia in vitro as well as in ex vivo 
MACS-purified CD11b+ microglia/macrophages from 
three disease models, namely: transient brain ischemia 
[3], Alzheimer’s-like pathology [4], and a chronic stress 
paradigm used to elicit anxious/depressive-like behaviors 
[5–7].
Abstract Microglia senescence may promote neuropsy-
chiatric disease. This prompted us to examine the relation-
ship between microglia activation states and telomere biol-
ogy. A panel of candidate genes associated with telomere 
maintenance, mitochondrial biogenesis, and cell-cycle 
regulation were investigated in M1- and M2-polarized 
microglia in vitro as well as in MACS-purified CD11b+ 
microglia/brain macrophages from models of stroke, Alz-
heimer’s disease, and chronic stress. M1 polarization, 
ischemia, and Alzheimer pathology elicited a strikingly 
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All experimental procedures were approved by the respec-
tive official committees and carried out in strict accord-
ance with the Animal Welfare Act, the European Commu-
nities Council Directive of November 24, 1986 (86/609/
EEC) and the ARRIVE (Animals in Research: Reporting 
In Vivo Experiments) guidelines [8]. Male 129/SV mice 
were 7–8 weeks old and weighed between 18 and 22 g at 
the beginning of experiments. APPPS1 mice [4] and wild-
type littermate controls were 6 months old at the time of 
the experiments. Animals were housed in standard mouse 
cages in groups of 4–6 mice per cage at 22–23 °C with a 
standard light–dark cycle (7 AM–7 PM). Animals were ran-
domized to experimental groups. Transient brain ischemia 
was induced by 30 min left filamentous middle cerebral 
artery occlusion (MCAo)/reperfusion as reported earlier 
[9]. The chronic stress procedure spanned 28 days and was 
carried out as described at length previously [6]. Briefly, 
the procedure consists of exposure to a rat, restraint stress, 
and tail suspension, which were applied in the following 
sequence: days 1–7, exposure to a rat; days 8–10, restraint 
stress; days 11–14, tail suspension; days 15–21, exposure 
to a rat; days 22–25, restraint stress; and days 26–28, tail 
suspension.
Microglia cultures
Cultures of primary murine microglia were prepared from 
newborn C57Bl6 mice (P0–3) as described previously [10, 
11]. In brief, microglial cells were harvested by gentle 
shake-off and seeded at an initial density of 106 cells/ml. 
Cells remained in culture for additional 24 h before use. 
The purity of cultures exceeded 98%, which was confirmed 
by regular flow cytometry analyses with CD11b and CD45 
staining (rat anti-mouse CD11b #553312 and rat anti-
mouse CD45 #553081: both from BD Biosciences). All 
experiments were performed in DMEM containing 10% 
fetal calf serum, 1% Pen/Strep, 1% sodium-pyruvate and 
4.5 g/l d-glucose (“complete medium”; all from Biochrom/
Merck KGaA). Recombinant murine IL-4 (PeproTech) was 
used at a concentration of 10 ng/ml [10]. LPS (Escherichia 
coli 055:B5, Sigma-Aldrich) was applied at a concentration 
of 1 μg/ml [11].
Ex vivo isolation of adult mouse microglia
All kits were from Miltenyi Biotec. Adult mice were 
perfused transcardially with 0.9% saline. After quick 
removal, brains were dissociated using the Neural 
Tissue Dissociation Kit (P) according to the manufactur-
er’s instructions. After dissociation, myelin was eliminated 
using Myelin Removal Beads. Finally, for magnetic cell 
sorting (“MACS”) via columns, the cell suspension was 
incubated with CD11b MicroBeads. In the stroke experi-
ments, microglia/macrophages were harvested from the 
infarcted tissue of the ipsilateral hemisphere (MCA terri-
tory). In the other experiments, whole brains including cer-
ebellum were used.
Messenger RNA isolation and quantitative polymerase 
chain reactions
We followed established protocols for mRNA isolation and 
quantitative polymerase chain reactions [3]. Total RNA 
was extracted using the NucleoSpin® Tissue XS kit (Mach-
erey–Nagel). For PCR amplification, we used gene-specific 
primers (Table 1) and Light Cycler® 480 SYBR Green I 
Master (Roche Diagnostics). Polymerase chain reaction 
conditions were as follows: preincubation 95 °C, 10 min; 
95 °C, 10 s, primer-specific annealing temperature, 10 s, 
72 °C, 15 s (45 cycles). Crossing points of amplified prod-
ucts were determined using the Second Derivative Maxi-
mum Method (Light Cycler 480 Version 1.5.0, Roche). 
Quantification of messenger RNA expression was rela-
tive to tripeptidyl peptidase (Tpp) 2 [12]. The specificity 
Table 1  Primer sequences used in quantitative real-time polymerase 
chain reactions
Primer For Rev
Nrf1 cca cgt tac agg gcg 
gtg aa
agt ggc tcc ctg ctg cat ct
Nfe2I2 = Nrf2 gca cag aag aaa gca 
ttg tg
agt gtg gtg agg tct ata tc
PGC1α cac gca gcc cta ttc att 
gtt cg
gct tct cgt gct ctt tgc 
ggt at
PGC1β caa cta tct ctc tga cac 
gca g
ctc act gtc aat ctg gaa 
gag c
Tfam ctt cga ttt tcc aca gaa 
cag c
ctt tgt atg ctt tcc act cag c
Terf1 ctt tcg tcg tac tcg tga cag gag ttc caa atc atc agg 
gct g
Terf2 cac acc ctt gga atc agc 
tat c
gtt cag gag atc agt tct 
cag c
Tert gtt gcc caa tgc cta gtg 
tgc
cac tcg gct caa cag tag 
cat c
Chek2 caa gaa cct gaa gaa cct 
ggt c
gct cgg tat tta cga agg 
ttc c
Trp53 gac agc caa gtc tgt tat 
gtg c
gtc ttc cag ata ctc ggg 
ata c
Cdkn1a = P21 gtg gaa ctt tga ctt cgt 
cac g
caa tct gcg ctt gga gtg 
ata g
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of polymerase chain reaction products was checked using 
melting curve analysis.
Statistical analysis
Experiments were carried out in a blinded fashion. Data 
are presented as mean ± SD. Groups were compared by 
unpaired t test with level of significance set at 0.05 and 
two-tailed p values using Graph-Pad Prism 6 (Graph-
dPad Software). For data sets which were not normally 
distributed, nonparametric testing was performed using 
the Mann–Whitney test (Cdkn1a in Fig. 1a, PGC1α in 
Fig. 1b, Terf1 in Fig. 1c). Analyses of LPS- and IL-4 stim-
ulated primary murine microglia are based on 4–5 inde-
pendent samples per condition (Fig. 1a, b). Analyses of 
CD11b+ adult microglia/brain macrophages are based on 
five sham-operated and six MCAo mice (stroke condition; 
Fig. 1c), 4 APPPS1 mice and 4 littermate controls (Alzhei-
mer’s model; Fig. 1d). In the stress condition, a sample of 
Cd11b+ MACS-sorted cells was pooled from 2 to 3 mice 
with 5 independent samples for the stress group and 6 inde-
pendent samples for the unstressed control group (Fig. 1e).
Results
A panel of key marker genes associated with mitochondrial 
biogenesis (Nrf1, Nfe2l2, PGC1α, PGC1β, Tfam), the tel-
omere complex (Terf1, Terf2, Tert) and cell-cycle regula-
tion (Chek2, Trp53, Cdkn1a) were investigated.
First, we studied gene expression in cultured primary 
murine microglia (Fig. 1a, b). LPS stimulation (Fig. 1a) 
and IL-4 stimulation (Fig. 1b) represent the two extremes of 
microglia polarization in vitro. Interestingly, the patterns of 
gene regulation differed profoundly between either condi-
tion. M1 microglia showed robust downregulation of Tfam 
as well as of genes associated with the telomere complex 
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Fig. 1  a Primary postnatal microglia cultures were treated with LPS 
(1 µg/ml, 6 h). N = 4–5 independent measurements per data point. b 
Primary postnatal microglia cultures were treated with IL-4 (10 ng/
ml, 24 h). N = 4–5 independent measurements per data point. c. 
After 7 days, CD11b+ cells were MACS-sorted from the brains of 
mice subjected to 30 min MCAo/reperfusion or to sham operation. 
N = 5–6 animals per group. d CD11b+ cells were MACS-sorted 
from the brain of 6-month-old APPPS1 animals and compared to 
wild-type littermates. N = 4 mice per group. e Upon completion of 
the chronic stress procedure, mice were sacrificed and CD11b+ 
cells were MACS-sorted from the brain. N = 5–6 mice per group. 
*p < 0.05, **p < 0.001, ***p < 0.0001
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of the cell-cycle regulators was strongly affected by LPS 
stimulation (Fig. 1a). M2-polarized, alternatively activated 
microglia showed an entirely different pattern with upregu-
lation of several genes associated with mitochondrial bio-
genesis and energy metabolism (Nfe2l2, PGC1α, PGC1β) 
as well as upregulation of tumor suppressor Trp53 (Fig. 1b).
Next, we studied gene expression in ex vivo isolated 
CD11b+ adult microglia/brain macrophages. The follow-
ing disease conditions were investigated: transient mild 
brain ischemia (Fig. 1c), a murine model of Alzheimer’s 
disease (Fig. 1d) as well as a 4-week chronic stress para-
digm (Fig. 1e). Strikingly, the pattern of effects observed 
in the ischemic brain 7 days after 30 min MCAo/reperfu-
sion closely recapitulated the findings in LPS-stimulated 
microglia in vitro with downregulation of Tfam, Terf1, 
Terf2, Tert, and upregulation of Cdkn1a (Fig. 1c). A simi-
lar, albeit weaker, pattern of effects also emerged in Alzhei-
mer’s-like brain with significant downregulation of Terf1, 
Tert, and upregulation of Cdkn1a (Fig. 1d). The 4-week 
stress paradigm did not exert strong effects on any of the 
telomere-associated molecules. Similarly, there was no 
apparent effect of chronic stress on cell-cycle regulation. 
Nfe2l2 mRNA expression was decreased in ex vivo isolated 
CD11b+ cells following chronic stress.
Discussion
Along with monocytes invading the brain parenchyma after 
injury, microglia constitute the main cellular effectors of 
innate immunity in the central nervous system. Activated 
microglia fulfill a plethora of functions including detection 
and removal of pathogens and debris, antigen presentation, 
secretion of cytokines and chemokines, resolution of neu-
roinflammation, and modulation of brain repair, e.g., by 
releasing neurotrophic factors [13]. In a relatively recent 
and surprising paradigm shift, microglia have come to the 
fore as key players across a wide range of neurological and 
neuropsychiatric disorders, in particular disorders related to 
aging such as stroke or Alzheimer’s disease [14, 15].
In the current study, we examined the effects of M1 
and M2 polarization of cultured murine microglia on a 
panel of key marker genes associated with the telomere 
complex, mitochondrial function, and cell-cycle regula-
tion (PGC network; [2]). Then, we compared these ideal-
typical patterns with mRNA regulation in MACS-sorted 
microglia/macrophages harvested from the brain of adult 
mice subjected to mild transient ischemia, chronic stress, 
or expressing mutant amyloid precursor protein. It should 
be specifically noted that all in vivo models investigated 
here represent subacute or chronic changes in activation 
states (i.e., 7 days after middle cerebral artery occlusion/
reperfusion; 6-month-old APPPS1 mice with established 
amyloid plaques [4]; 4-week stress model). We anticipate 
that the mRNA results presented here will serve as a refer-
ence for future studies of the PGC network in microglia/
brain macrophages under different physiological and dis-
ease conditions.
The strongest effects on our panel of candidate genes 
were observed after LPS stimulation of microglia in vitro, 
supporting the notion that along with a pronounced meta-
bolic shift (e.g., [10, 11, 16]), classical microglia activation 
elicits a robust transcriptomic response. The effects of IL-4 
followed an entirely different pattern from that of LPS. 
Furthermore, generally speaking, the effects of chronic 
stress were modest. By contrast, brain ischemia and, to a 
lesser degree, Alzheimer’s-like pathology yielded relatively 
similar patterns of mRNA changes to those observed after 
stimulation with LPS.
The most striking and unexpected finding of this study 
is that M1 polarization strongly represses genes associated 
with the telomere complex. Importantly, both ischemia and 
Alzheimer’s-like pathology recapitulated this cell type-
specific pattern of reduced Tert mRNA expression in vivo. 
A good correlation between telomerase activity and Tert 
mRNA expression has previously been reported (e.g., [17, 
18]). It is therefore likely that the transcriptomic changes 
observed here contribute directly to microglial cellular dys-
trophy and senescence such as is observed during aging and 
in aging-related neurodegenerative diseases (e.g., [19, 20]).
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